Hepatology News Tonight - Managing Complications of Cirrhosis

This activity was recorded at a satellite symposium event concurrent with the 2019 SHM Annual Conference. 

Target Audience

This activity has been designed to meet the educational needs of physicians, advanced practice providers and allied health professionals who provide care for hospitalized patients with  liver disease.

Learning Objectives

After completing this enduring activity, participants should be better able to:

  • Understand the complications and the consequences of cirrhosis
  • Describe the economic, patient, and caregiver burdens associated with cirrhosis
  • Demonstrate the ability to properly treat the complications of cirrhosis and prevent recurrence

Accredited by:

Rehoboth McKinley Christian Health Care Services

Provided by:

Chronic Liver Disease Foundation

Supported by educational grants from Mallinckrodt and Salix Pharmaceuticals.

Accreditation

Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS), the Chronic Liver Disease Foundation (CLDF), and the Texas Gulf Coast Gastroenterological Society (TGCGS). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-physician
Course opens: 
04/30/2019
Course expires: 
04/30/2020
Member cost:
$0.00
Your cost:
$0.00

Robert S. Brown, Jr., MD, MPH (Chair)
Gladys and Roland Harriman Professor of Medicine
Vice Chair for Mentorship and Academic Development
Clinical Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York
Dr. Brown reports the following relationships related to this activity:
Honoraria recipient: AbbVie, Dova, Gilead, Intercept, Merck, and Shionogi, Inc. 
Consultant/Research Support: AbbVie, Dova, Gilead, Intercept, Merck, and Shionogi, Inc. 

Kimberly Brown, MD, FAST, FAASLD, AGAF
Professor of Medicine at Wayne State University
Chief, Gastroenterology and Hepatology
Associate Medical Director, Henry Ford Hospital Transplant Institute
Henry Ford Hospital
Detroit, Michigan
Dr. Brown reports the following relationships related to this activity:
Honoraria recipient: Gilead, Pfizer, and Merck. 
Consultant/Research Support: Allergan, Conatus, Gilead, and Novartis.

Steven Flamm, MD, FAASLD, FACG
Chief of Hepatology and Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois
Dr. Flamm reports the following relationships related to this activity:
Honoraria recipient: Dova and Salix Pharmaceuticals. 
Consultant/Research Support: Dova and Salix Pharmaceuticals. 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS), the Chronic Liver Disease Foundation (CLDF) and the Texas Gulf Coast Gastroenterological Society (TGCGS). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-physician

Accreditation Period

Course opens: 
04/30/2019
Course expires: 
04/30/2020

Price

Member cost:
$0.00
Your cost:
$0.00
Please login or register to take this course.